TNFR2 is required for RIP1-dependent cell death in human leukemia.
Saved in:
| Title: | TNFR2 is required for RIP1-dependent cell death in human leukemia. |
|---|---|
| Authors: | Aguadé-Gorgorió J; Department of Oncology and Children's Research Centre, University Children's Hospital Zurich, Zürich, Switzerland., McComb S; Department of Oncology and Children's Research Centre, University Children's Hospital Zurich, Zürich, Switzerland., Eckert C; Department of Pediatric Oncology/Hematology, Charité Medical University Berlin, Berlin, Germany., Guinot A; Department of Oncology and Children's Research Centre, University Children's Hospital Zurich, Zürich, Switzerland., Marovca B; Department of Oncology and Children's Research Centre, University Children's Hospital Zurich, Zürich, Switzerland., Mezzatesta C; Department of Oncology and Children's Research Centre, University Children's Hospital Zurich, Zürich, Switzerland., Jenni S; Department of Oncology and Children's Research Centre, University Children's Hospital Zurich, Zürich, Switzerland., Abduli L; Department of Oncology and Children's Research Centre, University Children's Hospital Zurich, Zürich, Switzerland., Schrappe M; Department of General Pediatrics, University Hospital Schleswig-Holstein, Kiel, Germany; and., Dobay MP; Department of Oncology and Children's Research Centre, University Children's Hospital Zurich, Zürich, Switzerland., Stanulla M; Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany., von Stackelberg A; Department of Pediatric Oncology/Hematology, Charité Medical University Berlin, Berlin, Germany., Cario G; Department of General Pediatrics, University Hospital Schleswig-Holstein, Kiel, Germany; and., Bourquin JP; Department of Oncology and Children's Research Centre, University Children's Hospital Zurich, Zürich, Switzerland., Bornhauser BC; Department of Oncology and Children's Research Centre, University Children's Hospital Zurich, Zürich, Switzerland. |
| Source: | Blood advances [Blood Adv] 2020 Oct 13; Vol. 4 (19), pp. 4823-4833. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33027529 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: TNFR2 is required for RIP1-dependent cell death in human leukemia. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Aguadé-Gorgorió+J%22">Aguadé-Gorgorió J</searchLink>; Department of Oncology and Children's Research Centre, University Children's Hospital Zurich, Zürich, Switzerland.<br /><searchLink fieldCode="AU" term="%22McComb+S%22">McComb S</searchLink>; Department of Oncology and Children's Research Centre, University Children's Hospital Zurich, Zürich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Eckert+C%22">Eckert C</searchLink>; Department of Pediatric Oncology/Hematology, Charité Medical University Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Guinot+A%22">Guinot A</searchLink>; Department of Oncology and Children's Research Centre, University Children's Hospital Zurich, Zürich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Marovca+B%22">Marovca B</searchLink>; Department of Oncology and Children's Research Centre, University Children's Hospital Zurich, Zürich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Mezzatesta+C%22">Mezzatesta C</searchLink>; Department of Oncology and Children's Research Centre, University Children's Hospital Zurich, Zürich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Jenni+S%22">Jenni S</searchLink>; Department of Oncology and Children's Research Centre, University Children's Hospital Zurich, Zürich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Abduli+L%22">Abduli L</searchLink>; Department of Oncology and Children's Research Centre, University Children's Hospital Zurich, Zürich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Schrappe+M%22">Schrappe M</searchLink>; Department of General Pediatrics, University Hospital Schleswig-Holstein, Kiel, Germany; and.<br /><searchLink fieldCode="AU" term="%22Dobay+MP%22">Dobay MP</searchLink>; Department of Oncology and Children's Research Centre, University Children's Hospital Zurich, Zürich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Stanulla+M%22">Stanulla M</searchLink>; Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.<br /><searchLink fieldCode="AU" term="%22von+Stackelberg+A%22">von Stackelberg A</searchLink>; Department of Pediatric Oncology/Hematology, Charité Medical University Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Cario+G%22">Cario G</searchLink>; Department of General Pediatrics, University Hospital Schleswig-Holstein, Kiel, Germany; and.<br /><searchLink fieldCode="AU" term="%22Bourquin+JP%22">Bourquin JP</searchLink>; Department of Oncology and Children's Research Centre, University Children's Hospital Zurich, Zürich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Bornhauser+BC%22">Bornhauser BC</searchLink>; Department of Oncology and Children's Research Centre, University Children's Hospital Zurich, Zürich, Switzerland. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101698425%22">Blood advances</searchLink> [Blood Adv] 2020 Oct 13; Vol. 4 (19), pp. 4823-4833. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Hematology%22">American Society of Hematology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101698425 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-9537 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224739529%22">24739529 </searchLink><i>NLM ISO Abbreviation: </i>Blood Adv <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33027529 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1182/bloodadvances.2019000796 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 4823 Titles: – TitleFull: TNFR2 is required for RIP1-dependent cell death in human leukemia. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Aguadé-Gorgorió J – PersonEntity: Name: NameFull: McComb S – PersonEntity: Name: NameFull: Eckert C – PersonEntity: Name: NameFull: Guinot A – PersonEntity: Name: NameFull: Marovca B – PersonEntity: Name: NameFull: Mezzatesta C – PersonEntity: Name: NameFull: Jenni S – PersonEntity: Name: NameFull: Abduli L – PersonEntity: Name: NameFull: Schrappe M – PersonEntity: Name: NameFull: Dobay MP – PersonEntity: Name: NameFull: Stanulla M – PersonEntity: Name: NameFull: von Stackelberg A – PersonEntity: Name: NameFull: Cario G – PersonEntity: Name: NameFull: Bourquin JP – PersonEntity: Name: NameFull: Bornhauser BC IsPartOfRelationships: – BibEntity: Dates: – D: 13 M: 10 Text: 2020 Oct 13 Type: published Y: 2020 Identifiers: – Type: issn-electronic Value: 2473-9537 Numbering: – Type: volume Value: 4 – Type: issue Value: 19 Titles: – TitleFull: Blood advances Type: main |
| ResultId | 1 |